Heparanase Promotes Engraftment and Prevents Graft versus Host Disease in Stem Cell Transplantation

Menachem Bitan, Lola Weiss, Michael Zeira et al. · 2010

Read Heparanase Promotes Engraftment and Prevents Graft versus Host Disease in Stem Cell Transplantation by Menachem Bitan, Lola Weiss, Michael Zeira et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0010135.txt.

Description

The authors were Menachem Bitan, Lola Weiss, Michael Zeira, and others. Their 2010 PLOS ONE study used mice to test a transplant aid called heparanase. Heparanase is an enzyme that cuts sugar chains on cell surfaces. It is known for roles in cancer spread, new blood vessels, and inflammation.

In bone marrow transplants, mice making extra heparanase took grafts better. The enzyme also prevented graft versus host disease, where donor cells attack the patient. Both effects together could make stem cell transplants, a key leukemia treatment, safer and more reliable. Few transplant tools promise both gains together.

Catalog record

CREATORMenachem Bitan, Lola Weiss, Michael Zeira et al.
YEAR2010
COLLECTIONPAPERS
FORMATTXT
FILE SIZE50 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0010135

Browse the full library · About the Tower of Babel